Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Prostate cancer treatment devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Device type trends
2.5 End-use trends
Chapter 3 Prostate Cancer Treatment Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of prostate cancer
3.2.1.2 Technological advancements
3.2.1.3 Surging awareness and screening initiatives
3.2.1.4 Growing preference for non-invasive treatment options
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.3.1 By device type
3.3.4 By end use
3.4 COVID- 19 impact analysis
3.5 Number of prostate cancer procedures, at global level, 2022
3.6 Reimbursement scenario
3.7 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 Asia Pacific
3.8 Technology landscape
3.9 Role of devices in prostate cancer treatment
3.10 Future market trends
3.11 Porter's analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis
4.6 Strategy dashboard, 2022
Chapter 5 Prostate Cancer Treatment Devices Market Size and Forecast, By Device Type (USD Million)
5.1 Key trends, by device type
5.2 Radiation Treatment Devices
5.2.1 External Beam Radiation Therapy (EBRT)
5.2.2 Stereotactic Body Radiation Therapy (SBRT)
5.2.3 Proton Therapy
5.2.4 Brachytherapy
5.2.5 Others
5.3 Surgical Treatment Devices
5.3.1 Radical Prostatectomy
5.3.2 Robotic Surgery Systems
5.3.3 Laparoscopic Devices
5.3.4 Others
5.4 Ablation Treatment Devices
5.4.1 High-intensity Focused Ultrasound (HIFU)
5.4.2 Cryotherapy
5.4.3 Laser Ablation
5.4.4 Irreversible Electroporation (IRE)
5.4.5 Others
5.5 Others
Chapter 6 Prostate Cancer Treatment Devices Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Specialty Clinics
6.4 Ambulatory Surgical Centers
6.5 Cancer Research Institutes
6.6 Others
Chapter 7 Prostate Cancer Treatment Devices Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 Sweden
7.3.8 The Netherlands
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Thailand
7.4.7 Indonesia
7.4.8 Philippines
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Columbia
7.5.5 Chile
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Israel
7.6.5 Turkey
7.6.6 Iran
Chapter 8 Company Profiles
8.1 Intuitive Surgical
8.2 Varian Medical Systems
8.3 Elekta
8.4 EDAP TMS
8.5 SonaCare Medical
8.6 Medtronic
8.7 Profound Medical
8.8 AngioDynamics
8.9 Endocare
8.10 Boston Scientific
